Phase II clinical trial on systemic oxaliplatin chemotherapy plus molecular target therapy combined with hepatic arterial infusion (HAI) therapy for colorectal liver metastases

ABSTRACT: Interventions: Period of intervension: 8 cycles of chemotherapy, mainly for 6 months. Primary outcome(s): Two-year relative-free survival after liver surgery Overall survival Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2634755 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR